Three Drugs Purported To Be Manufactured By ‘Meg Lifesciences’ Are Spurious: DCA Telangana

Hyderabad: V.B. Kamalasan Reddy (IPS), Director General, Telangana DCA said in press release that “It has come to the attention of the Drugs Control Administration, Telangana, that certain drugs claimed on the label as manufactured by ‘Meg Lifesciences, Khasara No. 47/5, Palli Gaon, Distt. Sirmour, 173 001,’ are being circulated in the market. Upon investigation, it has been confirmed that ‘Meg Lifesciences’ is a fictitious/non-existent company. These drugs have been found to be falsified medicines, manufactured by anti-social elements, containing no active ingredient (‘Nil’ medicine). They have been found to contain chalk powder and starch, posing significant health risks to consumers.

In light of these grave findings, the Drugs Control Administration, Telangana, hereby issues a Spurious Drug Alert and Stop Use Notice for all drugs claiming to be manufactured by ‘Meg Lifesciences.’

Consumers and healthcare professionals are informed to ‘STOP USE’ immediately – to discontinue the use of any drugs claiming to be manufactured by ‘Meg Lifesciences.’

Retailers and wholesalers are directed to ‘STOP’ the sale and distribution of any drugs bearing the label of ‘Meg Lifesciences,’ and to inform the area Drugs Inspector immediately.”

The Drugs Control Administration, Telangana, is taking stringent measures to curb the menace of spurious drugs and has seized stocks claimed to be manufactured by Meg Lifesciences worth Rs. 33.35 lakhs during the recent raids carried out by DCA. Cases have been registered against several offenders involved in this spurious drugs racket.

DCA is actively working to ensure the removal of these spurious drugs from the market.

Drugs Control Administration urges the public to remain vigilant and report any information regarding the distribution or sale of drugs from this purported manufacturer ‘Meg Lifesciences’:

  • To the nearest Drugs Control Administration Office – You may report to the local Drugs Inspector or Assistant Director, Drug Control Administration. The details of the contact number and address of the office are available on the Drugs Control Administration, Telangana website https://dca.telangana.gov.in/ under the ‘Key Contacts’ section (or)
  • To the Drugs Control Administration, Telangana Toll-Free Number 1800-599-6969, which is operational from 10:30 am to 5:00 pm on all working days.” said the press release.

Related Posts

24-year-old woman dies during surgery; Five UP doctors booked for negligence

Ballia: In an alleged case of medical negligence, a case has been registered against five doctors at a private hospital in Ballia, Uttar Pradesh, following the death of a 24-year-old…

Extortion, Fake Medicines: The Fall Of Surat’s Yoga Guru

The yoga guru, who was arrested last week, misled people in the name of faith and Ayurveda, said investigators. Surat: Just days after Ahmedabad cops dismantled a massive fake currency…

Leave a Reply

Your email address will not be published. Required fields are marked *

You Missed

24-year-old woman dies during surgery; Five UP doctors booked for negligence

24-year-old woman dies during surgery; Five UP doctors booked for negligence

Extortion, Fake Medicines: The Fall Of Surat’s Yoga Guru

Extortion, Fake Medicines: The Fall Of Surat’s Yoga Guru

Taisho-controlled pharma giant DHG posts 9.4% net profit surge in 2025

Taisho-controlled pharma giant DHG posts 9.4% net profit surge in 2025

Ship of Domestic Medical Device Industry flounders, thanks to Israel-Iran War

Ship of Domestic Medical Device Industry flounders, thanks to Israel-Iran War

DCGI Cracks Down On 90 Unapproved Fixed-Dose Combinations: Cough Syrups, Vitamins, Diabetes Drugs Among Those Flagged For Sale Without Central Approval

DCGI Cracks Down On 90 Unapproved Fixed-Dose Combinations: Cough Syrups, Vitamins, Diabetes Drugs Among Those Flagged For Sale Without Central Approval

India’s drug body flags 90 unapproved FDC medicines, states told to take action

India’s drug body flags 90 unapproved FDC medicines, states told to take action